Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Abbisko’s small molecule drug pimicotinib has smashed the primary goal of a phase 3 trial for the treatment of tenosynovial ...

Rogers, chief scientific officer at Coronado Research, she shares insights on the evolving landscape of pharmaceutical ...

Gifthealth Partners with United Digestive to boost patient access and procedure prep. Gifthealth has announced a strategic ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Starget Pharma, an Israeli startup developing AI-powered precision therapies for difficult-to-treat cancers, has secured a $5.1 million investment from MD Anderson Cancer Center’s Cancer Focus fund.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia. Novartis’ Scemblix (asciminib) has received accelerated approval by the US FDA as a ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and obese adults with heart disease. Novo Nordisk has released data from the ...

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program. The Palomar Health Foundation recently completed its third annual Middle School Medical ...